An incurable itch: Head lice;Une démangeaison incurable: Les poux

Canadian Family Physician

Volumn 58, Issue 8, 2012, Pages

  Smith, Christine H ^b   Goldman, Ran D ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; IVERMECTIN; LINDANE; MALATHION; PERMETHRIN; PYRETHRIN; PYRETHROID;

ANEMIA; ARTICLE; BURNING SENSATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DYSPNEA; ERADICATION THERAPY; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; NEUROTOXICITY; PEDICULOSIS CAPITIS; PEDICULUS; SCALP PRURITUS; SINGLE DRUG DOSE; TREATMENT FAILURE; WHEEZING;

ANIMALS; ANTHELMINTICS; ANTI-INFECTIVE AGENTS; CHILD; HUMANS; INSECTICIDES; IVERMECTIN; LICE INFESTATIONS; PEDICULUS; PYRETHRINS; SCALP DERMATOSES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84865410372     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Nutanson I, Steen CJ, Schwartz RA, Janniger CK. Pediculus humanus capitis: an update. Acta Dermatovenerol Alp Panonica Adriat 2008;17(4):147-54, 156-7, 159.
2. Van der Wouden JC, Klootwijk T, Le Cleach L, Do G, Vander Stichele R, Knuistingh Neven A, et al. Interventions for treating head lice. Cochrane Database Syst Rev 2011;(10):CD009321. DOI:10.1002/14651858.CD009321
3. Teale A, Duggal H, Phillips W, Beaumont M, Pepperman A, Kay K. Head lice: evidence-based guidelines based on the Stafford Report 2012 update. West Lothian, UK: Public Health Medicine Environmental Group; 2012. Available from: www.phmeg.org.uk/education/online-resources/. Accessed 2012 Jun 26.
4. Balcioglu C, Burgess IF, Limoncu ME, Sahin MT, Ozbel Y, Bilac C, et al. Plastic detection comb better than visual screening for diagnosis of head louse infestation. Epidemiol Infect 2008;136(10):1425-31. Epub 2008 Jan 4.
5. Tebruegge M, Pantazidou A, Curtis N. What's bugging you? An update on the treatment of head lice infestation. Arch Dis Child Educ Pract Ed 2011;96(1):2-8. Epub 2010 Aug 5.
6. Burkhart CG, Burkhart CN. Safety and efficacy of pediculicides for head lice. Expert Opin Drug Saf 2006;5(1):169-79.
7. Downs AM. Managing head lice in an era of increasing resistance to insecticides. Am J Clin Dermatol 2004;5(3):169-77.
8. Feldmeier H. Pediculosis capitis: new insights into epidemiology, diagnosis and treatment. Eur J Clin Microbiol Infect Dis 2012 Mar 1. Epub ahead of print.
9. Head lice infestations: a clinical update. Paediatr Child Health 2008;13(8):692-704.
10. Hunter JA, Barker SC. Susceptibility of head lice (Pediculus humanus capitis) to pediculicides in Australia. Parasitol Res 2003;90(6):476-8. Epub 2003 Jun 26.
11. Marcoux D, Palma KG, Kaul N, Hodgdon H, Van Geest A, Previte DJ, et al. Pyrethroid pediculicide resistance of head lice in Canada evaluated by serial invasive signal amplification reaction. J Cutan Med Surg 2010;14(3):115-8.
12. Jones KN, English JC 3rd. Review of common therapeutic options in the United States for the treatment of pediculosis capitis. Clin Infect Dis 2003;36(11):1355-61. Epub 2003 May 22.
13. U.S. Food and Drug Administration [website]. FDA Public Health Advisory: safety of topical lindane products for the treatment of scabies and lice. Silver Spring, MD: U.S. Food and Drug Administration; 2009.
14. Nolan K, Kamrath J, Levitt J. Lindane toxicity: a comprehensive review of the medical literature. Pediatr Dermatol 2012;29(2):141-6. Epub 2011 Oct 13.
15. Roberts RJ, Casey D, Morgan DA, Petrovic M. Comparison of wet combing with malathion for treatment of head lice in the UK: a pragmatic randomised controlled trial. Lancet 2000;356(9229):540-4.
16. Chosidow O, Giraudeau B, Cottrell J, Izri A, Hofmann R, Mann SG, et al. Oral ivermectin versus malathion lotion for difficult-to-treat head lice. N Engl J Med 2010;362(10):896-905.
17. Lebwohl M, Clark L, Levitt J. Therapy for head lice based on life cycle, resistance, and safety considerations. Pediatrics 2007;119(5):965-74.